NCT06155916View on ClinicalTrials.gov

Sleep and Neuropathic Pain - Intervention Study on Pregabalin

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 22, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Neuropathic PainInsomniaSleep Disorder
Interventions
DRUG

Pregabalin

Pregabalin administration and titration to the highest dosage that the patient tolerates. The patient continues with the highest dose for one month and the pre-intervention studies are repeated.

Trial Locations (2)

00029

RECRUITING

Helsinki University Central Hospital, Helsinki

RECRUITING

Helsinki University Hospital, Department of Neurology, Helsinki

All Listed Sponsors
collaborator

University of Helsinki

OTHER

lead

Helsinki University Central Hospital

OTHER